Skip to main content
Advertisement
Advertisement
XGN
XGN logo
Exagen Inc. Common Stock
3.80
USD
Sponsored
-0.10
-2.56%
Nov 19, 15:59 UTC -5
Closed
exchange

After-Market

3.81

+0.01
+0.13%

Exagen Inc. Common Stock (XGN) Earnings

XGN Earnings Reports

Positive Surprise Ratio

XGN beat 22 of 29 last estimates.

76%

Next Report

Date of Next Report
Mar 08, 2027
Estimate for Q4 26 (Revenue/ EPS)
$18.25M
/
-$0.18
Implied change from Q3 26 (Revenue/ EPS)
-0.90%
/
-28.00%
Implied change from Q4 25 (Revenue/ EPS)
+9.75%
/
-10.00%

Exagen Inc. Common Stock earnings per share and revenue

On Nov 10, 2026, XGN reported earnings of -0.25 USD per share (EPS) for Q3 26, missing the estimate of -0.18 USD, resulting in a -35.35% surprise. Revenue reached 18.42 million, compared to an expected 18.53 million, with a -0.59% difference. The market reacted with a -25.92% price change (close before vs. close after earnings).
Looking ahead to Q4 26, -- analysts forecast an EPS of -0.18 USD, with revenue projected to reach 18.25 million USD, implying an decrease of -28.00% EPS, and decrease of -0.90% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Omeros Corporation
Report Date
Nov 16, 2026 For Q3 26
Estimate
$0.03
Actual
$0.06
Surprise
+96.08%
logo
Sanara MedTech Inc. Common Stock
Report Date
Nov 12, 2026 For Q3 26
Estimate
$0.06
Actual
-$0.16
Surprise
-361.44%
logo
Oramed Pharmaceuticals Inc.
Report Date
Nov 12, 2026 For Q3 26
Estimate
$0.43
Actual
$0.43
Surprise
-1.96%
logo
MacroGenics, Inc.
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.06
Actual
-$0.32
Surprise
-367.15%
logo
Glass House Brands Inc.
Report Date
Nov 16, 2026 For Q3 26
Estimate
-$0.04
Actual
-$0.14
Surprise
-191.06%
logo
Immucell Corp
Report Date
Nov 12, 2026 For Q3 26
Estimate
-
Actual
$0.10
Surprise
-
logo
FitLife Brands, Inc. Common Stock
Report Date
Nov 16, 2026 For Q3 26
Estimate
$0.24
Actual
$0.16
Surprise
-34.64%
logo
Rockwell Medical, Inc. (DE) Common Stock
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.13
Actual
-$0.37
Surprise
-179.03%
logo
Modular Medical, Inc. Common Stock
Report Date
Nov 16, 2026 For Q2 26
Estimate
-$0.10
Actual
-$0.90
Surprise
-782.35%
logo
Cytosorbents Corp.
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.91
Actual
-$0.57
Surprise
+36.82%
FAQ
For Q3 2026, Exagen Inc. Common Stock reported EPS of -$0.25, missing estimates by -35.35%, and revenue of $18.42M, -0.59% below expectations.
The stock price moved down -25.92%, changed from $7.10 before the earnings release to $5.26 the day after.
The next earning report is scheduled for Mar 08, 2027.
Based on -- analysts, Exagen Inc. Common Stock is expected to report EPS of -$0.18 and revenue of $18.25M for Q4 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement